Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Human Health HoldingsHKSE:01419 58 EBITDA Margin % is 17.24% as of Dec. 2025, which is 21% above its 10-year median of 14.22. GuruFocus rates HKSE:01419 with a GF Score™ of 58/100 and a GF Value™ of HK$0.81 (Fairly Valued). The stock has 3 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Human Health Holdings ranks better than 64.61% on this metric.
Human Health Holdings (HKSE:01419) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Human Health Holdings EBITDA Margin % Related Terms
Human Health Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Human Health Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01419 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Human Health Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Human Health Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Human Health Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Human Health Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Health Holdings (HKSE:01419) has a EBITDA Margin % of 17.24% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Human Health Holdings and its competitors. This is 21% above median its historical median of 14.22. Over the past decade, Human Health Holdings' EBITDA Margin % has ranged from 6.94 to 45.58. According to the industry distribution chart, Human Health Holdings ranks #235 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 35.4%.
Is Human Health Holdings' EBITDA Margin % too high?
Human Health Holdings' current EBITDA Margin % of 17.24% is 21% above median its 10-year median of 14.22. Over the past 10 years, this metric has ranged from a low of 6.94 to a high of 45.58. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Human Health Holdings' value of 17.24% is 68.9% above this industry median. Based on the distribution chart, Human Health Holdings ranks #235 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Human Health Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Human Health Holdings' EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Human Health Holdings ranks #235 out of 664 companies for EBITDA Margin %. This puts Human Health Holdings in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Human Health Holdings' value of 17.24% is 68.9% above this benchmark. Historically, Human Health Holdings' own EBITDA Margin % has ranged from 6.94 to 45.58 over the past decade. While the company's 10-year median is 14.22 vs. the industry median of 10.21, Human Health Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Human Health Holdings's current EBITDA Margin % of 17.24% is 68.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Human Health Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Human Health Holdings's current EBITDA Margin % is 17.24%, which is 21% above median its own 10-year median of 14.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Health Holdings stock overvalued right now?
Based on GuruFocus' analysis, Human Health Holdings (HKSE:01419) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.81, compared to a current price of HK$0.74 — trading 9.3% below its estimated fair value. The current EBITDA Margin % is 17.24%, which is 21% above median its 10-year median of 14.22 and 68.9% above the Healthcare Providers & Services industry median of 10.21. Human Health Holdings' overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Human Health Holdings (HKSE:01419), the current EBITDA Margin % is 17.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Human Health Holdings (HKSE:01419) Overvalued in 2026?
Based on GuruFocus' analysis, Human Health Holdings stock appears to be undervalued.
The current stock price of HK$0.74 is trading 9.3% below its estimated GF Value™ of HK$0.81.
GuruFocus considers Human Health Holdings to be Fairly Valued.
Key valuation signals for HKSE:01419:
EBITDA Margin %: 17.24% (21% above median its 10-year median of 14.22)
GF Value™: HK$0.81 vs. price of HK$0.74 (9.3% below fair value)
Industry Position: 68.9% above the Healthcare Providers & Services median (#235 of 664)
No single metric tells the full story. See the HKSE:01419 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Human Health Holdings Ltd is engaged in the provision of healthcare services. The company segments include general practice services, specialties services, and dental services. It offers general practice services, including general consultation, diagnostics, and preventative health, minor procedure, vaccination, physical check-up, health education, occupational health advisory, Cardiology, Dental Implant, Urology, work injury assessment services, Orthodontics and others. It generates maximum revenue from the general practice services segment.
58GF Score
Get the complete analysis for HKSE:01419
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01419 has been successfully added to your 
